Skip to main content
Premium Trial:

Request an Annual Quote

OmniViz Set for Aug. 31 Launch of Data-Mining Software Built With J&J

NEW YORK, Aug. 27 - OmniViz said it will release on Saturday new bioinformatics software co-developed by Johnson & Johnson's  pharmaceutical R&D arm.


The software allows researchers to mine data from various sources, including text and patent searches, clinical information, and genomic and proteomic data, according to Jeff Saffer, chief technology officer and acting president of OmniViz.


The technology was designed through an ongoing relationship with J&J, through which the pharma company gets early access to software updates and input in software design, said Saffer.


Though he declined to disclose what J&J pays for the early access, Saffer described the collaboration as a "long-term relationship."


Michael Jackson, vice president for drug discovery at R W Johnson Pharmaceutical Research Institute, said his bioinformatics staff is working closely with OmniViz. The software, he said, "mixes different data sources together. I believe this is where you have to go."


Maynard, Mass.-based OmniViz has a similar relationship with BASF Plant Sciences, said Saffer.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.